These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6282435)

  • 1. Evaluation of 5'-nucleotide phosphodiesterase isozyme-V as a predictor for liver metastasis in breast cancer patients.
    Tsou KC; Lo KW; Rosato EF; Yuk A; Enterline H; Schwegman C
    Cancer; 1982 Jul; 50(2):191-6. PubMed ID: 6282435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Nucleotide phosphodiesterase isozyme-V as a marker for liver metastases in breast cancer patients.
    Tsou KC; Creech RH; Inouye WY; Lo KW
    Cancer; 1984 Nov; 54(9):1788-93. PubMed ID: 6090000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 5'-nucleotide phosphodiesterase as a predictor of hepatic metastases in gastrointestinal cancer.
    Pollock TW; Mullen JL; Tsou KC; Lo KW; Rosato EF
    Am J Surg; 1979 Jan; 137(1):22-5. PubMed ID: 215045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of liver metastases with 5'-nucleotide phosphodiesterase isozyme-V in gastrointestinal cancer patients.
    Tsou KC; Lo KW; Herberman RB; Schutt AJ
    Oncology; 1980; 37(6):381-5. PubMed ID: 6253858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Tsude K; Sakai M; Sato T
    Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on serum 5'-nucleotide phosphodiesterase isoenzyme-V as a predictor of liver metastases in patients with gastric and colorectal cancers].
    Ogiwara H
    Nihon Geka Gakkai Zasshi; 1986 Aug; 87(8):859-69. PubMed ID: 3018474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 5'-nucleotide phosphodiesterase isozyme-V for detection of liver metastasis in patients with gastro-intestinal cancer.
    Tomoda H; Furusawa M; Ichino M
    Jpn J Clin Oncol; 1983 Jun; 13(2):353-60. PubMed ID: 6310182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of serum 5'-nucleotide phosphodies-terase isozyme-V (5'-NPD-V) on hepatocellular carcinoma and metastatic carcinoma of the liver (author's transl)].
    Kiyohashi A; Shibata H; Ozawa S; Ichino M; Aoyagi S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Jul; 78(7):1431-6. PubMed ID: 6171663
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum 5'--nucleotide phosphodiesterase isozyme--V test for human liver cancer.
    Tsou KC; Lo KW
    Cancer; 1980 Jan; 45(2):209-13. PubMed ID: 6153148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer.
    Kamby C; Dirksen H; Vejborg I; Daugaard S; Guldhammer B; Rossing N; Mouridsen HT
    Cancer; 1987 Apr; 59(8):1524-9. PubMed ID: 3545442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of new abnormal isoenzymes of 5'-nucleotide phosphodiesterase in the diagnosis of human liver cancer.
    Lin KM; Ye SY; Liu QF
    Int J Cancer; 1988 Jan; 41(1):30-2. PubMed ID: 2826344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5'-nucleotide phosphodiesterase isoenzyme-V (5'-NPD-V)].
    Ikeda Y; Takami H
    Nihon Rinsho; 1999 Dec; 57 Suppl():546-8. PubMed ID: 10778187
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver scanning in newly diagnosed breast carcinoma.
    Haid M; Singh J; Nevinny HB
    J Surg Oncol; 1980; 13(3):265-8. PubMed ID: 7374160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of 5'-nucleotide phosphodiesterase isoenzymes in normal and pathological sera.
    Lüthje J; Pickert S; Ogilvie A; Hornemann E; Siegfried W; Waldherr A; Domschke W
    Clin Chim Acta; 1988 Oct; 177(2):131-9. PubMed ID: 2853013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases].
    Wang JY; Xu BH; Tian LJ; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):612-6. PubMed ID: 17236558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal surveillance for postoperative metastasis in breast cancer patients.
    Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
    Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.